Status | Study |
Completed |
Study Name: Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2011-07-29 |
Active, not recruiting |
Study Name: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2011-06-20 Interventions: Drug: Octreotide-LAR 40 mg eve |
Completed |
Study Name: A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan] Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2010-12-06 Interventions: Drug: tolvaptan Repeated oral administration twice daily (morning and evening) at one of three split dos |
Completed |
Study Name: Bosutinib For Autosomal Dominant Polycystic Kidney Disease Condition: Polycystic Kidney, Autosomal Dominant Date: 2010-10-28 Interventions: Drug: Bosutinib Once daily ora |
Terminated |
Study Name: Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2010-10-12 Interventions: Drug: Sirolimus Patients will |
Completed |
Study Name: Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease Condition: Chronic Kidney Disease Polycystic Kidney, Autosomal Dominant Date: 2010-04-26 |
Completed |
Study Name: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002] Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2009-11-27 Interventions: Drug: OPC-41061 Repeated oral administration at doses of 15 mg twice daily (morning and evening) |
Completed |
Study Name: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001] Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2009-02-09 Interventions: Drug: OPC-41061 orally administered at 15 mg twice daily (morning and evening) for a maximum of 3 years. |
Completed |
Study Name: Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2008-09-24 Interventions: Other: Water prescription Water prescription in 12 to 16 equally divided doses |
Completed |
Study Name: Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2007-12-31 Interventions: Drug: Tetracosactin 1 microgram tetracosactin, intravenous injection, once for the test |